More on BYSI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (4.4 Score)

Upcoming Events

- Earnings (8/13/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BeyondSpring (NQ:BYSI)
Delayed: 1.45 -0.04 (2.68%)
Prev. Close $1.49  
Open$1.48 
52 Wk High$ 
52 Wk Low$ 
Day High$1.48 
Day Low$1.33 
P/E N/A  
EPS$ 
Volume27,192 


Feb 17, 2026 04:34 PM Form SCHEDULE 13G/A BeyondSpring Inc. Filed by: Huang Lan
Feb 13, 2026 04:29 PM Form SCHEDULE 13G/A BeyondSpring Inc. Filed by: Decheng Capital Management III (Cayman), LLC
Feb 9, 2026 07:15 AM BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference
Dec 15, 2025 04:30 PM Form 8-K BeyondSpring Inc. For: Dec 15
Dec 12, 2025 07:00 AM BeyondSpring presents positive Asian subset data for lung cancer treatment
Dec 12, 2025 07:00 AM BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a
Dec 11, 2025 07:02 AM BeyondSpring reports survival benefit in lung cancer study analysis
Dec 11, 2025 07:00 AM BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis
Nov 21, 2025 04:30 PM Form 8-K BeyondSpring Inc. For: Nov 17
Nov 17, 2025 04:31 PM Form 424B5 BeyondSpring Inc.
View All Articles

Entities mentioned with BYSI

View All Entities